Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-31, Stock:JNJ, The news for the past five days is as follows:
2018-01-24: NEWS1: NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit.NEWS2: Johnson & Johnson Stock Is In The Perfect Buy Zone.NEWS3: How Juno Therapeutics’ Cellular Immunotherapy Portfolio Could Help Celgene.NEWS4: Healthcare ETFs in Focus Post JNJ Q4 Results.NEWS5: Stock Market News For Jan 24, 2018.NEWS6: Here’s Why Toilet Paper, Razors, and Baby Diapers Are About to Get Cheaper.NEWS7: Stock Market News For Jan 24, 2018.NEWS8: Johnson & Johnson Dips Despite Posting a Strong Q4.NEWS9: Johnson & Johnson Stock Is In The Perfect Buy Zone.NEWS10: Healthcare ETFs in Focus Post JNJ Q4 Results.NEWS11: Why Amgen is a Top Socially Responsible Dividend Stock (AMGN).NEWS12: Health Care Sector Update for 01/24/2018: JNJ, PFE, ABT, MRK, AMGN, STML, AERI, BSX.NEWS13: Today’s Research Reports on Stocks to Watch: Johnson & Johnson and Procter & Gamble.NEWS14: Here's How to Find the Best Dividend Stocks.NEWS15: Weakness in the Dollar Could Spell Trouble for Stocks.NEWS16: Here&apos;s How to Find the Best Dividend Stocks.NEWS17: [$$] Johnson & Johnson Results Driven by Pharmaceutical Sales Growth.NEWS18: Stocks Flatline as VIX Remains Buoyant.
2018-01-25: NEWS1: Will Pfizer (PFE) Surpass Estimates This Earnings Season?.NEWS2: Markets Right Now: Stocks end a choppy day of trading mixed.NEWS3: Boeing, 3M Dominate DJIA on Thursday.NEWS4: Will Pfizer (PFE) Surpass Estimates This Earnings Season?.NEWS5: Pfizer's Rituxan Biosimilar Meets Endpoint in Phase III.NEWS6: SPTM, JPM, JNJ, MA: ETF Inflow Alert.NEWS7: Pfizer in 4Q17: Revenue Estimates Based on Geographies.NEWS8: Pfizer: Revenue Growth Is Expected in 4Q17.NEWS9: Pfizer&apos;s Rituxan Biosimilar Meets Endpoint in Phase III.NEWS10: Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms.NEWS11: Free Research Report as Johnson & Johnson’s Adjusted Earnings Rose to Outshine Forecasts.NEWS12: Celgene on the Street: Analysts Recommendations in January.NEWS13: Four Things to Know About the Q4 Earnings Season.NEWS14: Johnson & Johnson Down Small on Huge Loss -- What Gives?.NEWS15: Johnson & Johnson Down Small on Huge Loss -- What Gives?.NEWS16: Tax Reform Benefits More About Paying Down Debt Than M&A: BofA Merrill Lynch.
2018-01-26: NEWS1: Pfizer Inc. Stock Rises From the Dead, Deserves to Be in Your Portfolio.NEWS2: Pfizer Inc. Stock Rises From the Dead, Deserves to Be in Your Portfolio.NEWS3: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS4: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS5: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS6: Health care costs are still a crushing problem.NEWS7: Zacks Earnings Trends Highlights: Citigroup, Johnson & Johnson, IBM and General Electric.NEWS8: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS9: These Drug Companies Are Best Positioned to Fight a ‘Superbug’.NEWS10: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS11: Zacks Earnings Trends Highlights: Citigroup, Johnson & Johnson, IBM and General Electric.NEWS12: Pfizer’s 4Q17 Estimates: Products with Lower Sales.NEWS13: What to Expect for Novartis’s Subsidiary Alcon in 2018.NEWS14: New York City Sues Big Pharma For Opioid Epidemic, But Does The Lawsuit Make Sense?.NEWS15: What Are Pfizer’s Positive Growth Contributors?.
2018-01-29: NEWS1: Top Analyst Reports for Johnson & Johnson, Illinois Tool Works & BNY Mellon.NEWS2: Top Analyst Reports for Johnson & Johnson, Illinois Tool Works & BNY Mellon.NEWS3: Top Analyst Reports for Johnson & Johnson, Illinois Tool Works & BNY Mellon.NEWS4: Protagonist Therapeutics 'Poised For Upside,' Stifel Says.NEWS5: What to Expect in Pfizer's Q4 Earnings Results.NEWS6: What to Expect in Pfizer's Q4 Earnings Results.NEWS7: How Much Cash Is Amazon Holding Abroad?.NEWS8: What to Expect in Pfizer&apos;s Q4 Earnings Results.
2018-01-30: NEWS1: Eli Lilly’s 4Q17 Estimates: Human Pharmaceuticals Business.NEWS2: Better Buy: Intuitive Surgical vs. Johnson & Johnson.NEWS3: Better Buy: Intuitive Surgical vs. Johnson & Johnson.NEWS4: Johnson & Johnson’s Segment-Wise Performance in 4Q17.NEWS5: Better Buy: Intuitive Surgical vs. Johnson & Johnson.NEWS6: Pfizer's new tax rate higher than investors hoped, shares fall.NEWS7: US officials seek packaging fix for diarrhea-drug abuse.NEWS8: Johnson & Johnson’s Growth Rate for 4Q17.NEWS9: Analysts’ Estimates for Eli Lilly’s 4Q17 Earnings.NEWS10: Johnson & Johnson’s Revenues Rose 11.5% in 4Q17.NEWS11: Pfizer (PFE) Stock Falls Despite Q4 Earnings & Sales Beat.NEWS12: Pfizer (PFE) Stock Falls Despite Q4 Earnings & Sales Beat.NEWS13: FDA asks drugmakers to limit amount of opioid drug in packaging.NEWS14: Caution Flag Is Out on Johnson & Johnson's Stock.NEWS15: The Zacks Analyst Blog Highlights: Johnson & Johnson, Illinois Tool Works, Bank of New York Mellon, Ford and Capital One Financial.NEWS16: The Zacks Analyst Blog Highlights: Johnson & Johnson, Illinois Tool Works, Bank of New York Mellon, Ford and Capital One Financial.NEWS17: Diarrhea Drug Imodium Swept Up in Opioid Crisis Under FDA Rules.NEWS18: Pfizer profit tops estimates, books $11 bln tax gain.NEWS19: The Zacks Analyst Blog Highlights: Johnson & Johnson, Illinois Tool Works, Bank of New York Mellon, Ford and Capital One Financial.NEWS20: In Your 70s? 3 Stocks You Might Want to Buy.NEWS21: In Your 70s? 3 Stocks You Might Want to Buy.NEWS22: In Your 70s? 3 Stocks You Might Want to Buy.

Answer: Decrease